Vicarious Surgical (RBOT) - 2023 Q4 - Annual Results

Exhibit 99.1 Vicarious Surgical Reports Fourth Quarter and Full Year 2023 Financial Results Version 1.0 Surgical System On Track for Cadaveric Testing in the Spring Achieves Full Year 2023 Cash Burn Objective of $63.4 Million Narrows Full Year 2024 Cash Burn Guidance to Approximately $50 Million WALTHAM, Mass.-- (BUSINESS WIRE) – March 4, 2024 – Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outc ...